EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Heart–gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion

Jinxuan Zhao iD, Qi Zhang, Wei Cheng, Qing Dai, Zhonghai Wei, Meng Guo, Fu Chen iD, Shuaihua Qiao iD, Jiaxin Hu iD, Junzhuo Wang, Haiting Chen, Xue Bao iD und 4 weitere

Cardiovascular Research · 13.06.2023 · 119 (6) · 1390-1402

DOI: 10.1093/cvr/cvad023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 30.01.2023. Verfasst von Jinxuan Zhao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, MOE Key Laboratory of Model Animal for Disease Study, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing Unive…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Myocardial Reperfusion Injury, Myocardial Ischemia, Coronary Artery Disease. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of China, Key Projects of Science and Technology of Jiangsu Province, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Recent studies have suggested a key role of intestinal microbiota in pathological progress of multiple organs via immune modulation. However, the interactions between heart and gut microbiota remain to be fully elucidated. The aim of the study is to investigate the role of gut microbiota in the post-ischaemia/reperfusion (I/R) inflammatory microenvironment. Methods and results Here, we conducted a case-control study to explore the association of gut bacteria translocation products with inflammation biomarkers and I/R injury severity in ST-elevation myocardial infarction patients. Then, we used a mouse model to determine the effects of myocardial I/R injury on gut microbiota dysbiosis and translocation. Blooming of Proteobacteria was identified as a hallmark of post-I/R dysbiosis, which was associated with gut bacteria translocation. Abrogation of gut bacteria translocation by antibiotic cocktail alleviated myocardial I/R injury via mitigating excessive inflammation and attenuating myeloid cells mobilization, indicating the bidirectional heart–gut–microbiome–immune axis in myocardial I/R injury. Glucagon-like peptide 2 (GLP-2), an endocrine peptide produced by intestinal L-cells, was used in the experimental myocardial I/R model. GLP-2 administration restored gut microbiota disorder and prevented bacteria translocation, eventually attenuated myocardial I/R injury through alleviating systemic inflammation.

Conclusion

Our work identifies a bidirectional communication along the heart–gut–microbiome–immune axis in myocardial I/R injury and demonstrates gut bacteria translocation as a key regulator in amplifying inflammatory injury. Furthermore, our study sheds new light on the application of GLP-2 as a promising therapy targeting gut bacteria translocation in myocardial I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeMyocardial Reperfusion InjuryMyocardial IschemiaCoronary Artery DiseaseHeart InjuriesMiceAnimalsDysbiosisCase-Control StudiesInflammationIschemiaReperfusionCommunication

Stichwörter der Autor:innen

Bacteria translocationGlucagon-like peptide 2Gut microbiota dysbiosisInflammationMyocardial ischaemia/reperfusion injury

Autor:innen und Institutionen

  • Department of Cardiology, MOE Key Laboratory of Model Animal for Disease Study, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University, No. 321 Zhongshan Road, Nanj…
  • Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, No. 155 Hanzhong Road, Nanjing 210000, China.
  • Department of Radiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University, No. 321 Zhongshan Road, Nanjing 210008, China.

ORCID-Profile: Jinxuan Zhao, Fu Chen, Shuaihua Qiao, Jiaxin Hu, Xue Bao, Xuan Sun, Biao Xu, Jun Xie

Förderung

  • Natural Science Foundation of China
  • Key Projects of Science and Technology of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province
  • Science Fund for Distinguished Young Scholars
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhao, J., Zhang, Q., Cheng, W., Dai, Q., Wei, Z., Guo, M., Chen, F., Qiao, S., Hu, J., Wang, J., Chen, H., Bao, X., Mu, D., Sun, X., Xu, B., & Xie, J. (2023). Heart–gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion. Cardiovascular Research, 119(6), 1390-1402. https://doi.org/10.1093/cvr/cvad023

Vancouver

Zhao J, Zhang Q, Cheng W, Dai Q, Wei Z, Guo M, et al. Heart–gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion. Cardiovascular Research. 2023;119(6):1390-1402. doi:10.1093/cvr/cvad023

BibTeX
@article{Zhao2023,
  author = {Zhao, Jinxuan and Zhang, Qi and Cheng, Wei and Dai, Qing and Wei, Zhonghai and Guo, Meng and Chen, Fu and Qiao, Shuaihua and Hu, Jiaxin and Wang, Junzhuo and Chen, Haiting and Bao, Xue and Mu, Dan and Sun, Xuan and Xu, Biao and Xie, Jun},
  title = {Heart–gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia/reperfusion},
  journal = {Cardiovascular Research},
  year = {2023},
  volume = {119},
  number = {6},
  pages = {1390--1402},
  doi = {10.1093/cvr/cvad023}
}
Kostenlos starten →